Case number IPR2016-00189
Coherus BioSciences Inc. v. AbbVie Biotechnology Ltd. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Jul 14, 2017 | 57 | Patent Owner's Notice Of Appeal Download | |
| Jun 9, 2017 | 56 | Final Written Decision Download | |
| Mar 23, 2017 | 55 | Record of Oral Hearing Download | |
| Feb 13, 2017 | 54 | Petitioner's Updated Mandatory Notices Download | |
| Feb 10, 2017 | 52 | Patent Owner's Fifth Updated Mandatory Notices Download | |
| Feb 10, 2017 | 53 | Decision Granting Pro Hac Vice Motions Download | |
| Feb 3, 2017 | 51 | Petitioner's Motion for Pro Hac Vice Admission Download | |
| Feb 3, 2017 | 1059 | Declaration of Jon Singer in Support of Pro Hac Vice Admission Download | |
| Feb 2, 2017 | 50 | Order Trial Hearing Download | |
| Jan 23, 2017 | 49 | Petitioner's Revised Reply Download | |
| Jan 20, 2017 | 46 | Conduct of the Proceeding Download | |
| Jan 20, 2017 | 48 | Petitioner's Request for Oral Hearing Download | |
| Jan 20, 2017 | 47 | Patent Owner's Request for Oral Argument Download | |
| Jan 19, 2017 | 2218 | Rau, AKT RHEUMATOL (2000) (German Original) (High-resolution Version) Download | |
| Jan 19, 2017 | 45 | Patent Owner's Updated Exhibit List Download | |
| Jan 19, 2017 | 2219 | Transcript of January 17, 2017 Conference Call Download | |
| Jan 5, 2017 | 44 | Patent Owner's Objections to Evidence Download | |
| Dec 28, 2016 | 43 | Petitioner's Reply Download | |
| Dec 28, 2016 | 1058 | Deposition transcript of Allan Gibofsky, M.D. Download | |
| Dec 28, 2016 | 1056 | Deposition transcript of Jeffrey M. Sailstad Download | |
| Dec 28, 2016 | 1051 | Figure 2 of the van Gestel Chart Download | |
| Dec 28, 2016 | 1057 | Deposition transcript of Jerry A. Hausman, Ph.D. Download | |
| Dec 28, 2016 | 1050 | Development and Validation of the European League Against Rheumatism Response Criteria for Rheumatoid Arthritis Download | |
| Dec 28, 2016 | 1049 | Drug Makers Now Spend $5 Billion A Year On Advertising Download | |
| Dec 28, 2016 | 1052 | Optimizing Clinical Outcomes in Rheumatoid Arthritis Download | |
| Dec 28, 2016 | 1055 | Deposition transcript of Alexander A. Vinks, Ph.D. Download | |
| Dec 28, 2016 | 1054 | Deposition transcript of Brian E. Harvey, M.D. Download | |
| Dec 28, 2016 | 1053 | Current Therapeutic Agents and Treatment Paradigms for the Management of Rheumatoid Arthritis Download | |
| Dec 28, 2016 | 1044 | Review Article: Applying Pharmacokinetics to Optimise Dosing of Anti-TNF Biologics in Acute Severe Ulcerative Colitis Download | |
| Dec 28, 2016 | 1048 | Pharma¿¿¿s Ad Spend Vaults to $4.5B, With Big Spender Pfizer Leading the Way Download | |
| Dec 28, 2016 | 1046 | Patent Owner's Preliminary Response Download | |
| Dec 28, 2016 | 1045 | Birth of a Blockbuster Download | |
| Dec 28, 2016 | 1043 | Neonatal and Pediatric Pharmacology Download | |
| Dec 28, 2016 | 1047 | AbbVie Patent List Download | |
| Dec 28, 2016 | 1042 | Comparative Pharmacokinetics of the Carbapenems: Clinical Implications Download | |
| Dec 28, 2016 | 1040 | Pharmacokinetics & Protein Therapeutics Download | |
| Dec 28, 2016 | 1041 | Pediatric Psychopharmacology Principles Download | |
| Nov 1, 2016 | 41 | Updated Notice of Deposition of Dr. Alexander A. Vinks Download | |
| Nov 1, 2016 | 42 | Updated Notice of Deposition of Dr. Allan Gibofsky Download | |
| Oct 13, 2016 | 37 | Petitioner's Notice of Deposition of Dr. Allan Gibofsky Download | |
| Oct 13, 2016 | 38 | Petitioner's Notice of Deposition of Dr. Brian E. Harvey Download | |
| Oct 13, 2016 | 40 | Petitioner's Notice of Deposition of Mr. Jeffrey M. Sailstad Download | |
| Oct 13, 2016 | 36 | Petitioner's Notice of Deposition of Dr. Alexander A. Vinks Download | |
| Oct 13, 2016 | 39 | Petitioner's Notice of Deposition of Dr. Jerry A. Hausman Download | |
| Sep 20, 2016 | 35 | Petitioner's Objections to Evidence Download | |
| Sep 13, 2016 | 2147 | SEC Form 10-K for AbbVie Inc. (FY ended Dec. 31, 2015) Download | |
| Sep 13, 2016 | 2203 | Tak, ARTHRITIS & RHEUM. (2012) Download | |
| Sep 13, 2016 | 2150 | Anantharaman, FROST & SULLIVAN (July 20, 2004) Download | |
| Sep 13, 2016 | 2193 | ClinicalTrials.gov identifier NCT01262365 Download | |
| Sep 13, 2016 | 2186 | ClinicalTrials.gov identifier NCT00476996 Download | |
| Sep 13, 2016 | 2162 | Williams & Edwards, RHEUMATOLOGY (2006) Download | |
| Sep 13, 2016 | 2145 | Certolizumab pegol/CIMZIA label (Nov. 18, 2009) Download | |
| Sep 13, 2016 | 2194 | ClinicalTrials.gov identifier NCT02720120 Download | |
| Sep 13, 2016 | 2158 | Lisicki & Chu, POSTGRADUATE MEDICINE (2008) Download | |
| Sep 13, 2016 | 2184 | ClinicalTrials.gov identifier NCT00090129 Download | |
| Sep 13, 2016 | 2155 | Approval Letter for BL 103795/5110 (Oct. 17, 2003) Download | |
| Sep 13, 2016 | 2152 | Palmer, Top 10 rheumatoid arthritis drugs 2013 Download | |
| Sep 13, 2016 | 2179 | Genovese, ANN RHEUM DIS (2013) Download | |
| Sep 13, 2016 | 2144 | Approval Letter for 99-0128 (Nov. 10, 1999) Download | |
| Sep 13, 2016 | 2170 | Neef & Vinks, PHARMACEUTICS WEEKLY (2000) (English Translation) Download | |
| Sep 13, 2016 | 2171 | Neef & Vinks, PHARMACEUTISCH WEEKBLAD (2000) (Dutch Original) Download | |
| Sep 13, 2016 | 2204 | Torgerson, CONTROL. CLIN. TRIALS (2001) Download | |
| Sep 13, 2016 | 2187 | ClinicalTrials.gov identifier NCT00485589 Download | |
| Sep 13, 2016 | 2181 | Hamilton, CONTROLLED CLIN. TRIALS (2000) Download | |
| Sep 13, 2016 | 2199 | Philippidis, Top 10 Clinical Trial Failures of 2013 (Fed. 3, 2014) Download | |
| Sep 13, 2016 | 33 | Patent Owner's Response Download | |
| Sep 13, 2016 | 2160 | Abbott Labs., Press Release (June 26, 2006) Download | |
| Sep 13, 2016 | 2182 | Sacks, JAMA (2014) Download | |
| Sep 13, 2016 | 2143 | Supplemental Approval Letter for BLA 125057/S-397 (June 30, 2016) Download | |
| Sep 13, 2016 | 2206 | Wallace, ANN. RHEUM. DIS. (2014) Download | |
| Sep 13, 2016 | 2141 | Supplemental Approval Letter for BLA 125057/232 (Sept. 28, 2012) Download | |
| Sep 13, 2016 | 2156 | Chilton & Collett, MUSCULOSKELET. CARE (2008) Download | |
| Sep 13, 2016 | 2161 | Curtis, & Singh, CLIN. THER. (2011) Download | |
| Sep 13, 2016 | 2201 | Rayes & Touma, DRUG DESIGN, DEVELOPMENT AND THERAPY (2014) Download | |
| Sep 13, 2016 | 2189 | ClinicalTrials.gov identifier NCT00673920 Download | |
| Sep 13, 2016 | 2149 | SEC Form 10-K for Abbott Laboratories (FY ended Dec. 31, 2005) Download | |
| Sep 13, 2016 | 2192 | ClinicalTrials.gov identifier NCT01261793 Download | |
| Sep 13, 2016 | 2183 | ClinicalTrials.gov identifier NCT00077870 Download | |
| Sep 13, 2016 | 2166 | Abbott, Introducing More Reasons Than Ever To Choose Humira Download | |
| Sep 13, 2016 | 2167 | Abbott Labs., Helping Your RA Patients Live More Normal Lives Download | |
| Sep 13, 2016 | 2205 | Wallace, ARTHRITIS CARE & RES. (2016) Download | |
| Sep 13, 2016 | 2190 | ClinicalTrials.gov identifier NCT00785928 Download | |
| Sep 13, 2016 | 2154 | U.S. FDA, How Drugs are Developed and Approved Download | |
| Sep 13, 2016 | 2200 | Philippidis, Top 10 Clinical Trial Failures of 2014 (Feb. 9, 2015) Download | |
| Sep 13, 2016 | 2142 | Supplemental Approval Letter for BLA 125057/S-363 (Sept. 9, 2015) Download | |
| Sep 13, 2016 | 2180 | Genovese, ARTHRITIS & RHEUM. (2008) Download | |
| Sep 13, 2016 | 2176 | Emery, PLOS ONE (2014) Download | |
| Sep 13, 2016 | 2197 | Papp, CURRENT MED. RES. & OP. (2010) Download | |
| Sep 13, 2016 | 2174 | DiMasi, J. HEALTH ECON. (2003) Download | |
| Sep 13, 2016 | 2165 | Huynh, PATIENT PREFERENCES AND ADHERENCE (2014) Download | |
| Sep 13, 2016 | 2202 | Rigby, ARTHRITIS & RHEUM. (2012) Download | |
| Sep 13, 2016 | 2163 | Navarro-Mill¿¿n, PLOS ONE (2016) Download | |
| Sep 13, 2016 | 2191 | ClinicalTrials.gov identifier NCT01198002 Download | |
| Sep 13, 2016 | 2146 | Golimumab/SIMPONI label (Apr. 2009) Download | |
| Sep 13, 2016 | 2173 | Clowse, 2015 ACR/ARHP ANNUAL MEETING (2015) Download | |
| Sep 13, 2016 | 2172 | Curriculum Vitae of Dr. Brian E. Harvey Download | |
| Sep 13, 2016 | 2159 | Greenapple, AM. HEALTH DRUG BENEFITS (2012) Download | |
| Sep 13, 2016 | 2188 | ClinicalTrials.gov identifier NCT00624351 Download | |
| Sep 13, 2016 | 2185 | ClinicalTrials.gov identifier NCT00406419 Download | |
| Sep 13, 2016 | 2177 | Statement of Janet Woodcock (May 2, 2007) Download | |
| Sep 13, 2016 | 2151 | GlobalData, Top 50 pharmaceutical products by global sales Download | |
| Sep 13, 2016 | 2175 | D¿¿rner, ARTHRITIS RESEARCH THERAPY (2006) Download | |
| Sep 13, 2016 | 2164 | Sylwestrzak, AM. HEALTH DRUG BENEFITS (2014) Download | |
| Sep 13, 2016 | 34 | Patent Owner's Updated Exhibit List Download | |
| Sep 13, 2016 | 2195 | UCB Pharma Press Release, (Jul. 28, 2015) Download | |
| Sep 13, 2016 | 2198 | Philippidis, Top 10 Clinical Trial Failures of 2012 (Feb. 5, 2013) Download | |
| Sep 13, 2016 | 2153 | Berndt (1997) Download | |
| Sep 13, 2016 | 2169 | Supplemental Approval Letter for BLA 125057/356 (Sept. 23, 2014) Download | |
| Sep 13, 2016 | 2168 | Amgen, Press Release (July 20, 2006) Download | |
| Sep 13, 2016 | 2148 | SEC Form 10-K for Abbott Laboratories (FY ended Dec. 31, 2003) Download | |
| Sep 13, 2016 | 2157 | Louder, AM. HEALTH DRUG BENEFITS (2016) Download | |
| Sep 13, 2016 | 2103 | Mevorach & Paget (2000) Download | |
| Sep 13, 2016 | 2119 | Rowland & Tozer (1995) Download | |
| Sep 13, 2016 | 2046 | Baughman, PK/PD Study Strategies for Biopharmaceuticals (Oct. 14, 2009) Download | |
| Sep 13, 2016 | 2090 | Gibofsky, CURRENT MED. RES. & OP.(2006) Download | |
| Sep 13, 2016 | 2060 | O¿¿¿Dell, ARTHRITIS & RHEUMATISM (2011) Download | |
| Sep 13, 2016 | 2053 | Notices of Deposition of James O¿¿¿Dell Download | |
| Sep 13, 2016 | 2121 | Sailstad, THE AAPS JOURNAL (2014) Download | |
| Sep 13, 2016 | 2039 | CVS Caremark Primary/Preferred Drug List (Oct. 2010) Download | |
| Sep 13, 2016 | 2131 | Curriculum Vitae of Dr. Alexander A. Vinks Download | |
| Sep 13, 2016 | 2135 | MwPharm ver. 3.82 (update of ver. 3.60) (Feb. 16, 2014) Download | |
| Sep 13, 2016 | 2125 | Smolen, ANN. RHEUM. DIS. (2013) Download | |
| Sep 13, 2016 | 2077 | Kavanaugh, RHEUMATIC DISEASE CLINICS OF N. AM. (1998) Download | |
| Sep 13, 2016 | 2095 | Adalimumab (HUMIRA)Package Insert (Dec. 2002) Download | |
| Sep 13, 2016 | 2102 | Mayo Clinic Staff, Rheumatoid arthritis Download | |
| Sep 13, 2016 | 2076 | Ruderman & Tambar, Rheumatoid Arthritis Download | |
| Sep 13, 2016 | 2086 | Furst, J. RHEUMATOL. (2003) Download | |
| Sep 13, 2016 | 2127 | Taylor, ARTHRITIS & RHEUMATISM (2000) Download | |
| Sep 13, 2016 | 2059 | O¿¿¿Dell, ARTHRITIS & RHEUMATISM (2007) Download | |
| Sep 13, 2016 | 2087 | Furst, ANN. RHEUM. DIS. (2008) Download | |
| Sep 13, 2016 | 2082 | Points to Consider (Feb. 28, 1997) Download | |
| Sep 13, 2016 | 2052 | Denosumab/PROLIATM label (Jun. 2010) Download | |
| Sep 13, 2016 | 2066 | Declaration of Dr. Brian Harvey Download | |
| Sep 13, 2016 | 2040 | 2004 Express Scripts Nat'l Preferred Alpha Formulary List (Dec. 29, 2003) Download | |
| Sep 13, 2016 | 2129 | van de Putte, ANN. RHEUM. DIS. (2000) Download | |
| Sep 13, 2016 | 2044 | Notices of Deposition of Sharon Baughman Download | |
| Sep 13, 2016 | 2138 | Approval Letter for BL 12057/89 (Feb. 27, 2007) Download | |
| Sep 13, 2016 | 2058 | O¿¿¿Dell, NEW ENG. J. MED. (1996) Download | |
| Sep 13, 2016 | 2109 | MW\PHARM Ver. 3.15, Vols. 1-3 Download | |
| Sep 13, 2016 | 2070 | Transcript of Deposition of Brian Reisetter (Jul. 12, 2016) Download | |
| Sep 13, 2016 | 2104 | Miller, PHARMACEUTICAL RESEARCH (2001) Download | |
| Sep 13, 2016 | 2092 | Hanauer, AILMENT PHARMACOL. THER. (1999) Download | |
| Sep 13, 2016 | 2067 | Declaration of Dr. Jerry A. Hausman Download | |
| Sep 13, 2016 | 2107 | Moreland, ARTHRITIS & RHEUMATISM (1997) Download | |
| Sep 13, 2016 | 2081 | Eckardt & Casadevall, NEPHROL. DIAL. TRANSPLANT. (2003) Download | |
| Sep 13, 2016 | 2049 | Proudfoot (2002) Download | |
| Sep 13, 2016 | 2123 | Sander & Rau, INT¿¿¿L J. CLIN. PHARM. THERAPEUTICS (1998) Download | |
| Sep 13, 2016 | 2117 | Ross, ANN. NEUROL. (2000) Download | |
| Sep 13, 2016 | 2132 | Weaver, CURRENT MED. RES. & OP. (2006) Download | |
| Sep 13, 2016 | 2115 | Rau, AKT RHEUMATOL (2000) (German Original) Download | |
| Sep 13, 2016 | 2093 | Hasler, (1996) Download | |
| Sep 13, 2016 | 2133 | Weinblatt, TRANSACTIONS OF THE AM. CLIN. & CLIMATOLOGICAL ASS'n (2013) Download | |
| Sep 13, 2016 | 2079 | Christen, HUMAN IMMUNOLOGY (1999) Download | |
| Sep 13, 2016 | 2122 | Curriculum Vitae of Jeff Sailstad Download | |
| Sep 13, 2016 | 2071 | Errata for Transcript of Depo. of Brian Reisetter (Jul. 12, 2016) Download | |
| Sep 13, 2016 | 2096 | Guidance for Industry (Apr. 1996) Download | |
| Sep 13, 2016 | 2100 | The Lenercept MS Study Group, NEUROLOGY (1999) Download | |
| Sep 13, 2016 | 2134 | Curriculum Vitae of Dr. Jerry A. Hausman Download | |
| Sep 13, 2016 | 2038 | Exhibit D to the Williams Declaration (Feb. 7, 2014) Download | |
| Sep 13, 2016 | 2124 | Sedger & McDermott, CYTOKINE & GROWTH FACTOR REVIEWS (2014) Download | |
| Sep 13, 2016 | 2085 | Furst, Arthritis & Rheumatism (1996) Download | |
| Sep 13, 2016 | 2137 | Summary Review of sBLA 125057/110 (Jan. 16, 2008) Download | |
| Sep 13, 2016 | 2065 | Declaration of Dr. Allan Gibofsky Download | |
| Sep 13, 2016 | 2089 | Gibofsky, AM. J. MEDICINE (1997) Download | |
| Sep 13, 2016 | 2110 | Nestorov, J. RHEUMATOL. (2005) Download | |
| Sep 13, 2016 | 2116 | Review of BLA submission 99-O 128(Oct. 22, 1999) Download | |
| Sep 13, 2016 | 2074 | Transcript of Deposition of James O¿¿¿Dell (Sept. 1, 2016) Download | |
| Sep 13, 2016 | 2062 | O¿¿¿Dell, ANN. RHEUM. DIS. (1996) Download | |
| Sep 13, 2016 | 2057 | O¿¿¿Dell, ARTHRITIS & RHEUMATISM (2001) Download | |
| Sep 13, 2016 | 2113 | Rankin, BR. J. RHEUMATOL. (1995) Download | |
| Sep 13, 2016 | 2061 | O¿¿¿Dell, CURRENT RHEUMATOLOGY REPORTS (2000) Download | |
| Sep 13, 2016 | 2083 | Guidance for Industry (Feb. 1999) Download | |
| Sep 13, 2016 | 2050 | Cai (2011) Download | |
| Sep 13, 2016 | 2139 | Approval Letter for BL 125057/110 (Jan, 18, 2008) Download | |
| Sep 13, 2016 | 2130 | van de Putte, ANN. RHEUM. DIS. (2003) Download | |
| Sep 13, 2016 | 2140 | Approval Letter for sBLA 125057/114 (Feb. 21, 2008) Download | |
| Sep 13, 2016 | 2069 | Declaration of Dr. Alexander A. Vinks Download | |
| Sep 13, 2016 | 2047 | Trastuzumab/HERCEPTIN label (Mar. 2016) Download | |
| Sep 13, 2016 | 2063 | O¿¿¿Dell, MAYO CLIN. PROC. (2001) Download | |
| Sep 13, 2016 | 2072 | Transcript of Deposition of Sharon Baughman (Aug. 2, 2016) Download | |
| Sep 13, 2016 | 2084 | Findlay, J. PHARM. BIOMED. ANAL. (2000) Download | |
| Sep 13, 2016 | 2037 | Exhibit M to Williams Declaration (Feb. 7, 2014) Download | |
| Sep 13, 2016 | 2099 | Karlsson, BR. J. CLIN. PHARMACOL. (1998) Download | |
| Sep 13, 2016 | 2056 | O¿¿¿Dell, ARTHRITIS & RHEUMATISM (1999) Download | |
| Sep 13, 2016 | 2128 | Tishler, ANN. RHEUM. DIS. (1992) Download | |
| Sep 13, 2016 | 2043 | SEC Form 10-K for AbbVie Inc. (FY ended Dec. 31, 2013) Download | |
| Sep 13, 2016 | 2064 | Ziminski, MD, AM. J. OF MANAGED CARE (1999) Download | |
| Sep 13, 2016 | 2078 | Casadevall, NEPHROL. DIAL. TRANSPLANT. (2003) Download | |
| Sep 13, 2016 | 2106 | Mordenti, TOXICOLOGIC PATHOLOGY (1999) Download | |
| Sep 13, 2016 | 2136 | Approval Letter for BL 125057/45 (Oct. 3, 2005) Download | |
| Sep 13, 2016 | 2088 | Smolen, ANN. RHEUM. DIS. (2015) Download | |
| Sep 13, 2016 | 2041 | UnitedHealthcare 2013 Prescription Drug List Quick-Reference Guide Download | |
| Sep 13, 2016 | 2114 | Rau, AKT RHEUMATOL (2000) (English Translation) Download | |
| Sep 13, 2016 | 2118 | Rossert, J. AM. SOC. NEPHROL. (2004) Download | |
| Sep 13, 2016 | 2120 | Rowland & Tozer (2011) Download | |
| Sep 13, 2016 | 2055 | O¿¿¿Dell, CLIN. EXP. RHEUMATOL. (1999) Download | |
| Sep 13, 2016 | 2036 | Notices of Deposition of Brian Reisetter Download | |
| Sep 13, 2016 | 2126 | Stephens, IMMUNOLOGY (1995) Download | |
| Sep 13, 2016 | 2073 | Errata for Transcript of Depo. of Sharon Baughman (Aug. 2, 2016) Download | |
| Sep 13, 2016 | 2098 | Bingham & Ruffing, Rheumatoid Arthritis Treatment Download | |
| Sep 13, 2016 | 2091 | Curriculum Vitae of Dr. Allan Gibofsky Download | |
| Sep 13, 2016 | 2105 | Mire-Sluis, J. IMMUNOLOGICAL METHODS (2004) Download | |
| Sep 13, 2016 | 2068 | Declaration of Jeffrey M. Sailstad Download | |
| Sep 13, 2016 | 2111 | Rheumatoid Arthritis: What is Rheumatoid Arthritis? Download | |
| Sep 13, 2016 | 2101 | Maini & Feldmann, ARTHRITIS RES. (2002) Download | |
| Sep 13, 2016 | 2042 | Lobb (2007) Download | |
| Sep 13, 2016 | 2097 | Ruffing & Bingham, Rheumatoid Arthritis Signs and Symptoms Download | |
| Sep 13, 2016 | 2112 | Prevoo, ARTHRITIS & RHEUMATISM (1995) Download | |
| Sep 13, 2016 | 2051 | Furst (2003) Download | |
| Sep 13, 2016 | 2048 | Baselga, SEMIN. ONCOL. (1999) Download | |
| Sep 13, 2016 | 2045 | Feldmann & Maini, ANNU. REV. IMMUNOL. (2001) Download | |
| Sep 13, 2016 | 2108 | Moreland, J. RHEUMATOL. (2000) Download | |
| Sep 13, 2016 | 2094 | Approval Letter, Adalimumab (HUMIRA) (Dec. 31, 2002) Download | |
| Sep 13, 2016 | 2054 | Wolfe, J. RHEUMATOL. (2001) Download | |
| Sep 13, 2016 | 2080 | Clark, IMMUNOLOGY TODAY (2000) Download | |
| Aug 11, 2016 | 32 | Notice of Deposition of James O'Dell, M.D. Download | |
| Jul 28, 2016 | 31 | Petitioner's Notice of Designation of Additional Back-Up Counsel Download | |
| Jul 25, 2016 | 30 | Patent Owner's Power of Attorney Download | |
| Jul 25, 2016 | 29 | Patent Owner's Fourth Updated Mandatory Notices Download | |
| Jul 20, 2016 | 28 | Order - PO's Pro Hac Vice Motion for William McElwain and Amy Wigmore Download | |
| Jul 20, 2016 | 2034 | Declaration of William G. McElwain Download | |
| Jul 20, 2016 | 2035 | Declaration of Amy K. Wigmore Download | |
| Jul 14, 2016 | 27 | Decision Denying Patent Owner's Request for Rehearing Download | |
| Jul 13, 2016 | 26 | Notice of Deposition of Sharon Baughman, Ph.D. Download | |
| Jul 12, 2016 | 22 | Patent Owner's Updated Exhibit List Download | |
| Jul 12, 2016 | 24 | Exhibit 2034 - Declaration of William G. McElwain Download | |
| Jul 12, 2016 | 23 | Exhibit 2033 - RESERVED Download | |
| Jul 12, 2016 | 25 | Exhibit 2035 - Declaration of Amy K. Wigmore Download | |
| Jul 12, 2016 | 21 | Patent Owner's Motion for Admission Pro Hac Vice of Amy K. Wigmore Download | |
| Jul 12, 2016 | 20 | Patent Owner's Motion for Admission Pro Hac Vice of William G. McElwain Download | |
| Jul 11, 2016 | 19 | Order- Petitioner's Motion for Pro Hac Vice Admission of John C. Adkisson Download | |
| Jul 1, 2016 | 18 | petitioner | Petitioner's Motion for Pro Hac Vice Admission of John C. Adkisson Download |
| Jul 1, 2016 | 1036 | petitioner | Declaration of John Adkisson in Support of Pro Hac Vice Admission Download |
| Jun 30, 2016 | 16 | board | Order Revising the Schedule Download |
| Jun 30, 2016 | 17 | patent_owner | Patent Owner's Third Updated Mandatory Notices Download |
| Jun 29, 2016 | 15 | patent_owner | Notice of Deposition of Brian Reisetter, Ph.D. Download |
| Jun 23, 2016 | 14 | patent_owner | Patent Owner's Objections to Evidence Download |
| Jun 22, 2016 | 13 | patent_owner | Joint Proposal for a Stipulated Schedule Download |
| Jun 16, 2016 | 11 | patent_owner | Patent Owner's Second Updated Mandatory Notices Download |
| Jun 16, 2016 | 12 | patent_owner | Patent Owner's Request for Rehearing Download |
| Jun 16, 2016 | 10 | patent_owner | Power of Attorney Download |
| Jun 13, 2016 | 8 | board | Decision - Institution of Inter Partes Review - 37 CFR 42.108 Download |
| Jun 13, 2016 | 9 | board | Scheduling Order Download |
| Mar 15, 2016 | 7 | patent_owner | Patent Owner's Preliminary Response Download |
| Mar 15, 2016 | 2029 | patent_owner | Exhibit 2029 - Amendment and Response to Office Action (Jan. 29, 2008) Download |
| Mar 15, 2016 | 2010 | patent_owner | Exhibit 2010 - Daclizumab/ZENAPAX label Download |
| Mar 15, 2016 | 2028 | patent_owner | Exhibit 2028 - Bross, et al. (June 2001) Download |
| Mar 15, 2016 | 2018 | patent_owner | Exhibit 2018 - Porter and Charman (2000) Download |
| Mar 15, 2016 | 2019 | patent_owner | Exhibit 2019 - Rau 1999 (original German) Download |
| Mar 15, 2016 | 2012 | patent_owner | Exhibit 2012 - Palivizumab/SYNAGIS label Download |
| Mar 15, 2016 | 2017 | patent_owner | Exhibit 2017 - Rowland and Tozer (3d ed. 1995) Download |
| Mar 15, 2016 | 2014 | patent_owner | Exhibit 2014 - Alemtuzumab/CAMPATH label Download |
| Mar 15, 2016 | 2013 | patent_owner | Exhibit 2013 - Gemtuzumab/MYLOTARG label Download |
| Mar 15, 2016 | 2005 | patent_owner | Exhibit 2005 - Kupper I Declaration Download |
| Mar 15, 2016 | 2031 | patent_owner | Exhibit 2031 - Timmerman (Apr. 16, 2012) Download |
| Mar 15, 2016 | 2021 | patent_owner | Exhibit 2021 - van de Putte, et al. (2004) Download |
| Mar 15, 2016 | 2024 | patent_owner | Exhibit 2024 - Maini, et al. (1998) Download |
| Mar 15, 2016 | 2006 | patent_owner | Exhibit 2006 - Kupper II Declaration Download |
| Mar 15, 2016 | 2003 | patent_owner | Exhibit 2003 - Declaration of Diane R. Mould Download |
| Mar 15, 2016 | 2023 | patent_owner | Exhibit 2023 - van Schouwenburg, et al. (2013) Download |
| Mar 15, 2016 | 2025 | patent_owner | Exhibit 2025 - Wolfe, et al. (2001) Download |
| Mar 15, 2016 | 2022 | patent_owner | Exhibit 2022 - Vincent, et al. (2013) Download |
| Mar 15, 2016 | 2032 | patent_owner | Exhibit 2032 - the '135 Patent Download |
| Mar 15, 2016 | 2030 | patent_owner | Exhibit 2030 - Direct Narrative Statement of Brian C. Reisetter Download |
| Mar 15, 2016 | 2011 | patent_owner | Exhibit 2011 - Basiliximab/SIMULECT label Download |
| Mar 15, 2016 | 2007 | patent_owner | Exhibit 2007 - Rituximab/RITUXIN label Download |
| Mar 15, 2016 | 2020 | patent_owner | Exhibit 2020 - Rau 1999 (certified English translation) Download |
| Mar 15, 2016 | 2002 | patent_owner | Exhibit 2002 - Declaration of Michael E. Weinblatt Download |
| Mar 15, 2016 | 2027 | patent_owner | Exhibit 2027 - An (2010) Download |
| Mar 15, 2016 | 2015 | patent_owner | Exhibit 2015 - Adalimumab M10-261 Clinical Study Report Download |
| Mar 15, 2016 | 2008 | patent_owner | Exhibit 2008 - Trastuzumab/HERCEPTIN label Download |
| Mar 15, 2016 | 2009 | patent_owner | Exhibit 2009 - Abciximab/REOPRO label Download |
| Mar 15, 2016 | 2004 | patent_owner | Exhibit 2004 - Declaration of Mr. Medgar Williams Download |
| Mar 15, 2016 | 2026 | patent_owner | Exhibit 2026 - O'Dell (G.C. Tsokos et al. ed. 2002) Download |
| Mar 15, 2016 | 2016 | patent_owner | Exhibit 2016 - Kress (Dec. 24, 2002) Download |
| Mar 15, 2016 | 2001 | patent_owner | Exhibit 2001 - Declaration of Janet Pope Download |
| Feb 18, 2016 | 6 | patent_owner | Patent Owner's Updated Mandatory Notices Download |
| Dec 18, 2015 | 4 | potential_po | Power of Attorney Download |
| Dec 18, 2015 | 5 | potential_po | Related Matters Download |
| Dec 15, 2015 | 3 | board | Notice of Filing Date Accorded to Petition Download |
| Dec 7, 2015 | 2 | petitioner | Petition for Inter Partes Review of U.S. Patent No. 9,073,987 Download |
| Dec 7, 2015 | 1006 | petitioner | Declaration of Dr. Sharon Baughman Download |
| Dec 7, 2015 | 1007 | petitioner | Declaration of Dr. James ODell Download |
| Dec 7, 2015 | 1025 | petitioner | Declaration of Dr. Brian Reisetter Download |
| Dec 7, 2015 | 1004 | petitioner | Efficacy of the Fully Human Anti-TNF Antibody D2E7 in Rheumatoid Arthritis Download |
| Dec 7, 2015 | 1 | petitioner | Power of Attorney Download |
| Dec 7, 2015 | 1003 | petitioner | Preliminary results of early clinical trials with the fully human TNFa monoclonal antibody D2E7 Download |
| Dec 7, 2015 | 1001 | petitioner | U.S. Patent No. 9,073,987 Download |
| Dec 7, 2015 | 1027 | petitioner | Certolizumab/CIMZIA label Download |
| Dec 7, 2015 | 1012 | petitioner | Infliximab/REMICADE label Download |
| Dec 7, 2015 | 1026 | petitioner | Exhibit L to Declaration of Medgar Williams Download |
| Dec 7, 2015 | 1022 | petitioner | WO98/004281 Download |
| Dec 7, 2015 | 1032 | petitioner | 2015 Express Scripts Basic Formulary Download |
| Dec 7, 2015 | 1013 | petitioner | The Human IgG Subclasses Download |
| Dec 7, 2015 | 1029 | petitioner | MM and M 2014 Large Pharma Marketing Team of the Year Humira Download |
| Dec 7, 2015 | 1002 | petitioner | U.S. Prosecution History of U.S. Patent No. 8,889,135 Download |
| Dec 7, 2015 | 1005 | petitioner | Effective Combination of the Fully Human Anti-TNF Antibody D2E7 and Methotrexate in Active Rheumatoid Arthritis Download |
| Dec 7, 2015 | 1018 | petitioner | Long-Term Efficacy and Tolerability of Multiple I.V. Doses of the Fully Human Anti-TNF-Antibody D2E7 in Patients with Rheumaoid Arthritis Download |
| Dec 7, 2015 | 1017 | petitioner | A Single Dose Placebo Controlled Phase I Study of the Fully Human Anti-TNF Antibody D2E7 in Patients with Rheumatoid Arthritis Download |
| Dec 7, 2015 | 1028 | petitioner | Golimumab/SIMPONI label Download |
| Dec 7, 2015 | 1021 | petitioner | REMICADE Summary Basis of Approval Download |
| Dec 7, 2015 | 1019 | petitioner | Efficacy and Tolerability of Weekly Subcutaneous Injections of the Fully Human Anti-TNF-Antibody D2E7 in Patiens with Rheumatoid Arthritis-Results of a Phase I Study Download |
| Dec 7, 2015 | 1031 | petitioner | CVS/caremark Performance Drug List Download |
| Dec 7, 2015 | 1035 | petitioner | U.S. Prosecution History of U.S. Patent No. 9,073,987 Download |
| Dec 7, 2015 | 1020 | petitioner | ENBREL Summary Basis of Approval Download |
| Dec 7, 2015 | 1023 | petitioner | A dose escalation study designed to demonstrate the safety, tolerability and efficacy of the fully human anti-TNF antibody, D2E7, given in combination with methotrexate (MTX) in patients with active RA Download |
| Dec 7, 2015 | 1010 | petitioner | Dorlands Illustrated Medical Dictionary Download |
| Dec 7, 2015 | 1030 | petitioner | DTC Report DTC Gets Smart Download |
| Dec 7, 2015 | 1033 | petitioner | UnitedHealthcare 2015 Four-Tier Prescription Drug List Download |
| Dec 7, 2015 | 1015 | petitioner | Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases Download |
| Dec 7, 2015 | 1008 | petitioner | U.S. Patent No. 6,090,382 Download |
| Dec 7, 2015 | 1014 | petitioner | Methotrexate (Rheumatrex, Trexall, Otrexup, Rasuvo) Download |
| Dec 7, 2015 | 1011 | petitioner | Etanercept/ENBREL label Download |
| Dec 7, 2015 | 1009 | petitioner | Long-term treatment with the fully human anti TNF alpha-antibody D2E7 slows radio-graphic disease progression in rheumatoid arthritis Download |
| Dec 7, 2015 | 1034 | petitioner | Adalimumab/HUMIRA label Download |
| Dec 7, 2015 | 1016 | petitioner | Clinical Development Programs for Drugs, Devices and Biological Products for the Treatment of Rheumatoid Arthritis Download |
| Dec 7, 2015 | 1024 | petitioner | Arthritis and Rheum., vol. 42 Download |
